Literature DB >> 33564002

Purification of anti-glycoconjugate monoclonal antibodies using newly developed porous zirconia particles.

Tetsuya Okuda1, Katsuya Kato2, Masahiro Kitamura2, Shinjiro Kasahara3.   

Abstract

Here, we describe porous zirconia particles (PZPs) optimized for the purification of immunoglobulins. PZPs, with a pore size of approximately 10 nm, were designed to specifically interact with antibodies via surface modification with a phosphate functional group. A simple PZP purification method based on precipitation enabled efficient purification of mouse anti-glycosphingolipid globoside/Gb4Cer monoclonal IgM (κ-light chains) from hybridoma culture supernatants. Over 99% of contaminating proteins were removed by the PZP purification process, and approximately 50% of the IgM was recovered in the purified fraction after eluting the PZP-adsorbed antibodies with 100 mM phosphate buffer. Other IgG3 and IgM monoclonal antibodies that react with Gb4Cer or α2,6-sialyl LacNAc-modified glycoproteins could also be purified using PZPs and elution buffer at concentrations of 100-500 mM. All of the purified antibodies retained their antigen reactivity and specificity, indicating that PZP purification does not affect antibody function. As PZP purification is also suitable for purification of IgM consisting of λ-light chains and IgG derived from other mammalian species, it is expected to be applied to the purification of a variety of antibodies, including anti-glycoconjugate IgMs.

Entities:  

Year:  2021        PMID: 33564002     DOI: 10.1038/s41598-021-82457-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

1.  Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1.

Authors:  Stephanie Brändlein; Ines Beyer; Matthias Eck; Wolfgang Bernhardt; Frank Hensel; Hans Konrad Müller-Hermelink; H Peter Vollmers
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

2.  PUGNAc treatment provokes globotetraosylceramide accumulation in human umbilical vein endothelial cells.

Authors:  Tetsuya Okuda
Journal:  Biochem Biophys Res Commun       Date:  2017-04-06       Impact factor: 3.575

3.  Differential expression of alpha2-6 sialylated polylactosamine structures by human B and T cells.

Authors:  B Kniep; K Schäkel; M Nimtz; R Schwartz-Albiez; M Schmitz; H Northoff; R Vilella; M Gramatzki; E P Rieber
Journal:  Glycobiology       Date:  1999-04       Impact factor: 4.313

4.  Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.

Authors:  R Kannagi; Y Fukushi; T Tachikawa; A Noda; S Shin; K Shigeta; N Hiraiwa; Y Fukuda; T Inamoto; S Hakomori
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

5.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

6.  Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma.

Authors:  Reiko F Irie; David W Ollila; Steven O'Day; Donald L Morton
Journal:  Cancer Immunol Immunother       Date:  2003-10-16       Impact factor: 6.968

7.  Generation of anti-oligosaccharide antibodies that recognize mammalian glycoproteins by immunization with a novel artificial glycosphingolipid.

Authors:  Tetsuya Okuda; Asami Fukui
Journal:  Biochem Biophys Res Commun       Date:  2018-02-16       Impact factor: 3.575

8.  Differentiation-dependent expression of I and sialyl I antigens in the developing lung of human embryos and in lung cancers.

Authors:  S Itai; J Nishikata; N Takahashi; O Tanaka; Y Matsubara; S Hasegawa; N Yanai; K Takaoka; S Arii; T Tobe
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

9.  Quantitative Near-Infrared Imaging of Platelets in Platelet-Rich Fibrin (PRF) Matrices: Comparative Analysis of Bio-PRF, Leukocyte-Rich PRF, Advanced-PRF and Concentrated Growth Factors.

Authors:  Hachidai Aizawa; Tetsuhiro Tsujino; Taisuke Watanabe; Kazushige Isobe; Yutaka Kitamura; Atsushi Sato; Sadahiro Yamaguchi; Hajime Okudera; Kazuhiro Okuda; Tomoyuki Kawase
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

10.  Induction of specific adaptive immune responses by immunization with newly designed artificial glycosphingolipids.

Authors:  Tetsuya Okuda; Kayoko Shimizu; Satoshi Hasaba; Mutsuhiro Date
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.